Notícias Structure Therapeutics Inc - GPCR | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Structure Therapeutics Inc (GPCR)
Structure Therapeutics Inc (GPCR) Notícias

Structure Therapeutics Inc (GPCR)

22,34

-1,41

(-5,94%)

Fechado 04 Março 6:00PM

Atrasado por 15 minutos

22,00

-0,34

(-1,52%)

Após o horário de negociação: 9:29PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

Form 8-K - Current report

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity

Structure Therapeutics to Participate in the Jefferies London Healthcare Conference

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights

Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Structure Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições